The independent medical news service
26-11-2020 | Oncology | News | Article
Oligometastatic cancer outcomes acceptable with SABR
Stereotactic ablative radiotherapy is associated with “clinically acceptable” rates of toxicity, local control, progression-free survival, and overall survival in people with oligometastatic cancer, meta-analysis data suggest.
12-03-2020 | Oncology | News | Article
Metastases progression linked to deteriorating HRQoL
Disease progression among patients with metastatic lung, pancreatic, colorectal, and breast cancer is associated with statistically significant and clinically relevant reductions in health-related quality of life, real-world study data show.